Items in cart [0] Questions? Call 888-624-8373

PAPERBACK list:$26.00 Web:$23.40 add to cart Rights & Permissions Free PDF Access Free Resources Sign in to download PDF book and chapters PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles The Smallpox Vaccination Program: Public Health in an Age of Terrorism Immunization Safety Review: Vaccines and Autism Other Related Titles Risk Communication and Vaccination: Workshop Summary (1997) Board on Health Promotion and Disease Prevention (HPDP) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 27   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Workshop Agenda INSTITUTE OF MEDICINE VACCINE SAFETY FORUM Workshop on Risk Communication and Vaccination May 13, 1996 8:00 a.m. Risk Communication Overview Introduction: Geoffrey Evans, Vaccine Injury Compensation Program   Overview of Risk Communication and Vaccine Risk Communication: Ann Bostrom, Georgia Institute of Technology 9:00 a.m. Issues of Ethics, Medical Decisionmaking, and Informed Consent David Walsh, Catholic University of America; Douglas MacLean, University of Maryland 9:45 a.m. BREAK 10:00 a.m. Stakeholders: Roles, Expectations, Perceptions Media: Cristine Russell, Health Correspondent; Peggy O'Mara, Mothering Magazine   Consumer: Barbara Loe Fisher, National Vaccine Information Center, Rosemarie McLaren, Children's Defense Fund   Government: Martin Wasserman, Maryland Department of Health and Mental Hygiene   Provider: Sanford Kimmel, Medical College of Ohio Page 27 Front Matter (R1-R8) Executive Summary (1-2) Introduction and Background (3-3) Risk Perception and Decisionmaking (4-8) Influence on the Acceptability of Vaccine Risks (9-14) Current Communications Efforts (15-18) Improving Vaccine Risk Communications (19-20) Summary (21-22) References (23-26) Workshop Agenda (27-32) Appendix: Examples of Vaccine Information Statements (33-35)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 27
--> Workshop Agenda INSTITUTE OF MEDICINE VACCINE SAFETY FORUM Workshop on Risk Communication and Vaccination May 13, 1996 8:00 a.m. Risk Communication Overview Introduction: Geoffrey Evans, Vaccine Injury Compensation Program   Overview of Risk Communication and Vaccine Risk Communication: Ann Bostrom, Georgia Institute of Technology 9:00 a.m. Issues of Ethics, Medical Decisionmaking, and Informed Consent David Walsh, Catholic University of America; Douglas MacLean, University of Maryland 9:45 a.m. BREAK 10:00 a.m. Stakeholders: Roles, Expectations, Perceptions Media: Cristine Russell, Health Correspondent; Peggy O'Mara, Mothering Magazine   Consumer: Barbara Loe Fisher, National Vaccine Information Center, Rosemarie McLaren, Children's Defense Fund   Government: Martin Wasserman, Maryland Department of Health and Mental Hygiene   Provider: Sanford Kimmel, Medical College of Ohio

OCR for page 28
-->   Industry: Jill Hackell, Lederle-Praxis Biologicals; Carlton Meschievitz , Pasteur Mérieux Connaught   Legal: Peter Meyers, George Washington University 12:00 p.m. LUNCH 1:00 p.m. Current Information on Vaccine Risk Communication Activities Government: John Anderton, Centers for Disease Control and Prevention   Vaccine Information Statements: Sharon Humiston, University of Rochester   Industry: Robert Sharrar, Merck Research Laboratories   Consumer: Barbara Loe Fisher, National Vaccine Information Center 2:40 p.m. BREAK 3:00 p.m. PANEL I: Risk Communicators Moderator: Ann Bostrom   Ann Fisher, Pennsylvania State University; Douglas MacLean, University of Maryland; Jon Merz, University of Pennsylvania; Jacqueline Meszaros , Temple University   Open Discussion 4:00 p.m. PANEL II: Stakeholders Moderator: Ann Bostrom, Barbara Loe Fisher, National Vaccine Information Center; Jill Hackell , Lederle-Praxis Biologicals; Sanford Kimmel, Medical College of Ohio; Peter Meyers, George Washington University; Peggy O'Mara, Mothering Magazine; Frances Phillips, Department of Health, Ann Arundel County, Maryland; Judith Randal, Science Journalist; Cristine Russell, Health Correspondent

OCR for page 29
-->   Open Discussion 5:30 p.m. Closing Comments: Richard B. Johnston, Chair, Vaccine Safety Forum Participants List John Anderton, Health Communications Specialist, Centers for Disease Control and Prevention, Atlanta, Georgia Norman Baylor, Associate Director for Regulatory Policy, Food and Drug Administration, Rockville, Maryland Joan Blair, Program Analyst, Food and Drug Administration, Rockville, Maryland Ann Bostrom, Assistant Professor, School of Public Policy, Georgia Institute of Technology, Atlanta, Georgia Miles Braun, Medical Officer, Food and Drug Administration, Rockville, Maryland David Davis, Technical Information Specialist, Food and Drug Administration, Rockville, Maryland Jody Devoll, Consultant, Women's Health/Health Communications, Takoma Park, Maryland Susan Ellenberg, Director, Division of Biostatistics and Epidemiology, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland Geoffrey Evans, Chief Medical Officer, Division of Vaccine Injury Compensation, Rockville, Maryland Ann Fisher, Department of Agricultural Economics and Rural Sociology, Pennsylvania State University, University Park, Pennsylvania Barbara Loe Fisher, President, National Vaccine Information Center, Vienna, Virginia Kristina Fjeld, Immunizations, American State Territorial Health Officials, Washington, D.C. Joan Fusco, Director, Business Development, North American Vaccine, Inc., Rockville, Maryland Eugene Gangarosa, Private Consultant, Stone Mountain, Georgia Judy Gantt, Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia Elizabeth Goss, Fox, Bennett, Turner, Washington, D.C. Rich Greenaway, Program Manager for Childhood Immunizations, American Nurses Association, Washington, D.C. Cynthia J. Howe, Project Director, Institute of Medicine, Washington, D.C.

OCR for page 30
--> Sharon Humiston, Pediatrician, University of Rochester, Rochester, New York Richard B. Johnston, Jr., Adjunct Professor of Pediatrics, Yale University School of Medicine, and Medical Director, March of Dimes Birth Defects Foundation, White Plains, New York Sanford Kimmel, Department of Family Medicine, Medical College of Ohio, Toledo, Ohio Robert C. Kohberger, Director, Statistics and Data Management, Wyeth-Lederle Vaccines and Pediatrics, Pearl River, New York Carol Krueger, VAERS Project Officer, Food and Drug Administration, Rockville, Maryland Dale Lawrence, Chief Medical Officer for Vaccine Science, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland Douglas MacLean, Department of Philosophy, University of Maryland, Baltimore, Maryland Dorothy Majewski, Senior Project Assistant, Institute of Medicine, Washington, D.C. Rosie McLaren, Immunization Coordinator, Children's Defense Fund, Washington, D.C. Maryjane Mercer, Editor, Mothering Magazine, Sante Fe, New Mexico Jon F. Merz, Research Assistant Professor of Bioethics, University of Pennsylvania, Philadelphia, Pennsylvania Carlton Meschievitz, Executive Director, Medical Affairs, Connaught Laboratories, Inc., Swiftwater, Pennsylvania Jacqueline R. Meszaros, Assistant Professor of Management Science, Temple University, Philadelphia, Pennsylvania Peter H. Meyers, Professor, School of Law, George Washington University, Washington, D.C. Anne Moorehead, Research Nurse, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland J.A. Morris, Chairman of the Board, The Bell of Atri, Inc., College Park, Maryland Peggy O'Mara, Publisher and Editor, Mothering Magazine, Santa Fe, New Mexico Peter Patriarca, Deputy Director, Division of Viral Products, Food and Drug Administration, Rockville, Maryland Frances B. Phillips, Health Officer, Ann Arundel County Department of Health, Annapolis, Maryland Lynelle Phillips, Nurse Consultant, Vaccine Safety and Development, Centers for Disease Control and Prevention, Atlanta, Georgia Robert Pless, Head, Vaccine-Associated Adverse Events Surveillance Section, Division of Immunization, Health Canada, Ontario Judith Randal, Science Journalist, Lovettsville, Virginia

OCR for page 31
--> Suresh Rastogi, Deputy Director, DBE, Food and Drug Administration, Rockville, Maryland Peter Reeve, Biologist, Division of Viral Products, Food and Drug Administration Valencia Rodgers, Project Director, IEAC, Washington, D.C. Cristine Russell, Special Health Correspondent, Washington Post, Darien, Connecticut Marcel Salive, Chief, Epidemiology Branch, Food and Drug Administration, Rockville, Maryland Amy Sheon, Health Specialist, Division of AIDS, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland Kathleen R. Stratton, Deputy Director, Division of Health Promotion and Disease Prevention, Institute of Medicine, Washington, D.C. Michael A. Stoto., Director, Division of Health Promotion and Disease Prevention, Institute of Medicine, Washington, D.C. Brian Strom, Chair, Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania Linda Sussman, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland Jeanette Trauth, Assistant Professor, University of Pittsburgh, Pittsburgh, Pennsylvania Martin Wasserman, Secretary, Department of Health and Mental Hygiene, State of Maryland, Baltimore, Maryland Chris Watts, Research Nurse, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland Robert Wise, Medical Epidemiologist, Food and Drug Administration, Rockville, Maryland Skip Wolfe, Education and Training Specialist, Centers for Disease Control and Prevention, Atlanta, Georgia Kathi Williams, Director, National Vaccine Information Center, Vienna, Virginia

OCR for page 32
This page in the original is blank.

Representative terms from entire chapter:

information center